Adcock Ingram $1.3 Billion Acquisition Target Of Chile's CFR Pharma
This article was originally published in PharmAsia News
Executive Summary
Adcock Ingram, South Africa's second-largest drug maker is considering a $1.3 billion buyout by Chile's CFR Pharmaceuticals seeking its antiretrovirals and over-the-counter drugs.